Wednesday, April 18, 2007

Institute asks for people to test drug
Blue Springs Examiner - Blue Springs / Independence,MO,USA
The drug, known as FTY720, is in its third phase of
development and testing, which seeks to confirm
data demonstrated in the second phase of testing. ...
See all stories on this topic

Takeda, Eisai Takeovers Raise Biotech Costs for Merck, Novartis
Bloomberg - USA
Biogen Idec Inc.'s Tysabri costs $28400 a year.
Products of US biotechnology companies accounted
for $40.3 billion, or 15 percent, of drug purchases last ...
See all stories on this topic

Tysabri reduces vision loss in recurring multiple sclerosis
Earthtimes.org - USA
The drug called natalizumab (brand name Tysabri)
is commonly used in MS patients to reduce disability
and to also slow down possible relapse. ...
See all stories on this topic



0 Comments:

Post a Comment

<< Home